Session Type
Meeting
Search Results for Heart Failure
Abstract Number: 131
SHM Converge 2023
Background: Management of heart failure (HF) patients revolves around optimization of guideline directed medical therapy (GDMT) and routine monitoring. Substance use plays a major role as the etiology of HF, especially in a low socioeconomic area with ethnic and racial minority patients. The aim of this study is to find the correlation of alcohol, tobacco […]
Abstract Number: 132
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Despite recent advancements in the medical management of acute and chronic Heart Failure (HF), smooth transitions of care for patients hospitalized with HF remain elusive for most health care systems. Use of home health services and other ancillary services have been promoted in recent years as a means of reducing readmission rates among HF […]
Abstract Number: 139
Hospital Medicine 2020, Virtual Competition
Background: Mitochondrial disease (MD) refers to a group of clinically heterogeneous disorders that result from dysfunctional oxidative phosphorylation and subsequent cellular incapability to meet energy demands. Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), myoclonus, epilepsy, ataxia with ragged red fibers (MERRFs), chronic progressive ophthalmoplegia, Kearns–Sayre syndrome, and sensory ataxia neuropathy dysarthria ophthalmoplegia are among […]
Abstract Number: 141
Hospital Medicine 2020, Virtual Competition
Background: In patients hospitalized with heart failure (HF) exacerbations, physicians routinely supplement potassium to maintain levels ≥4.0 mEq/L. The evidence basis for this practice is relatively weak. We aimed to evaluate the association between serum potassium levels and outcomes in patients hospitalized with HF. Methods: We identified patients admitted with acute HF exacerbations to hospitals […]
Abstract Number: 146
SHM Converge 2024
Background: The diagnosis of sepsis is often associated with high rates of morbidity and mortality. When it occurs in patients with Heart failure (HF), those rates increase dramatically. This study focuses on the differences in the outcomes in septic patients with Heart Failure with preserved Ejection Fraction (HFpEF) versus patients with Heart Failure with reduced […]
Abstract Number: 151
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Hyperlipidemia is a recognized risk factor for incident acute myocardial infarction (AMI) and acute decompensated heart failure (ADHF), and no such documented association with pneumonia. However, the influence of hyperlipidemia on long-term mortality after AMI, HF, or pneumonia has not yet been fully understood. The objectives are to estimate the effect of hyperlipidemia and […]
Abstract Number: 151
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Congestive heart failure is a leading cause of hospitalization in adults greater than 65 years old. It is estimated that over 1 million people are hospitalized annually with a primary diagnosis of heart failure. Given the challenges of heart failure management, readmission within 30 days of hospital discharge is estimated to be 24%. […]
Abstract Number: 153
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Involvement of a cardiologist in the care of hospitalized patients with a primary diagnosis of heart failure (HF) has been shown to improve outcomes and may affect their readmission rates. However, less is known about the patients admitted for a different reason who carry a secondary diagnosis of HF and the effect of cardiology […]
Abstract Number: 156
Hospital Medicine 2020, Virtual Competition
Background: We have presented our experience with a novel percutaneous approach for axillary artery implant of intra-aortic balloon pumps. The axillary approach permits up-right posture and ambulation, but such enhanced mobility may predispose to higher risk of IABP malposition with unique complications. We present a few complications here. Methods: We conducted a retrospective review of […]
Abstract Number: 160
SHM Converge 2023
Background: The key goals of HF therapy are to prevent progression of symptoms, improve quality of life, and prolong survival. Studies have attempted to study and improve post hospitalization outcomes among patients with HF. Social determinants of Health include a wide set of factors from daily life which are responsible for health inequity. Burden of […]